Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Public ClinicalTrials.gov record NCT01016834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label Evaluation of Treatment Satisfaction, Tolerability, Safety and Preference for Sumavel DosePro for Treatment of Migraine in Subjects Currently Treated With Triptans
Study identification
- NCT ID
- NCT01016834
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Zogenix, Inc.
- Industry
- Enrollment
- 246 participants
Conditions and interventions
Conditions
Interventions
- Sumavel DosePro Device
- Sumatriptan Drug
Device · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 29, 2009
- Primary completion
- Apr 29, 2010
- Completion
- Apr 29, 2010
- Last update posted
- Jun 7, 2026
2009 – 2010
United States locations
- U.S. sites
- 21
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Hospital, Dept. of Neurology | Birmingham | Alabama | 35233 | — |
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| C. Phillip O'Carroll, MD, Inc | Newport Beach | California | 92660 | — |
| California Medical Clinic for Headache | Santa Monica | California | 90404 | — |
| Alpine Clinical Research | Boulder | Colorado | 80304 | — |
| University Clinical Research Inc. | Pembroke Pines | Florida | 33024 | — |
| Comprehensive Neuroscience Inc | St. Petersburg | Florida | 33716 | — |
| Comprehensive Neurosciences Inc | Atlanta | Georgia | 30328 | — |
| Neurology Specialists of Decatur | Decatur | Georgia | 30033 | — |
| Diamond Headache Clinic | Chicago | Illinois | 60614 | — |
| Michigan Head, Pain, & Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| Clinvest/A Division of Banyan Group, Inc | Springfield | Missouri | 65807 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Meridian Clinical Research | Omaha | Nebraska | 68134 | — |
| Regional Clinical Research Inc | Endwell | New York | 13760 | — |
| Headache Wellness Center | Greensboro | North Carolina | 27405 | — |
| Cleveland Clinic: Neurological Center for Pain | Cleveland | Ohio | 33195 | — |
| Jefferson Headache Center | Philadelphia | Pennsylvania | 19107 | — |
| Neurological Medicine | Clarksville | Tennessee | 37043 | — |
| Nashville Neuroscience Group | Nashville | Tennessee | 37203 | — |
| Swedish Pain and Headache Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01016834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2026 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01016834 live on ClinicalTrials.gov.